GTC Biotherapeutics (fka GTCB)

[ThomasS]

o/t: Noted. However, since biotech stock investing is essentially "informed gambling," I like the odds on this wager.
As an aside, the current market cap certainly ascribes little value to the remaining clinical pipeline, with perhaps too much inclination torwards the HD trial.

Remember your quote from April 2005 on Yahoo at @ $.88, something like: "If there's a better biotech value out there, I'd sure like to know?"